日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma

复发/难治性弥漫性大B细胞淋巴瘤CAR-T细胞疗法疗效的微生物组和代谢物生物标志物

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025016858
Yoon, Sang Eun; Kang, Woorim; Cho, Junhun; Cho, Hyeon Ji; Chalita, Mauricio; Oh, Hyun-Seok; Hyun, Dong-Wook; Han, Sujeong; Kim, Hyun; Sung, Hojun; Lee, Jae-Yun; Park, Bon; Ryu, Kyung Ju; Kim, Hyun-Young; Cho, Duck; Kim, Won Seog; Kim, Seok Jin
B细胞
T细胞
淋巴瘤
代谢
微生物学
T细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Optimization of Natural Killer Cell Expansion with K562-mbIL-18/-21 Feeder Cells and Assurance of Feeder Cell-free Products

利用K562-mbIL-18/-21饲养细胞优化自然杀伤细胞扩增并确保无饲养细胞产品

期刊:Annals of Laboratory Medicine
影响因子:3.9
doi:10.3343/alm.2025.0168
Jo, Hantae; Jo, Yujung; Koh, Seung Kwon; Lee, Mijeong; Kim, Jinho; Kweon, SoonHo; Park, Jeehun; Kim, Hyun-Young; Cho, Duck
自然杀伤细胞
细胞生物学
IL-18
发表日期：2026
文献求助 收藏

Natural Killer Cell Assays: Clinical Applications and Future Directions

自然杀伤细胞检测：临床应用及未来方向

期刊:Annals of Laboratory Medicine
影响因子:3.9
doi:10.3343/alm.2025.0508
Nam, Minjeong; Park, Wooseok; Kim, Hyun-Young; Cho, Duck
自然杀伤细胞
细胞生物学
发表日期：2026
文献求助 收藏

Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma

在复发或难治性大B细胞淋巴瘤患者中，polatuzumab vedotin联合苯达莫司汀和利妥昔单抗的真实世界应用

期刊:Korean Journal of Internal Medicine
影响因子:2.4
doi:10.3904/kjim.2025.282
Kim, Changgon; Yoon, Sang Eun; Kim, Hyun-Young; Cho, Duck; Cho, Junhun; Kim, Won Seog; Kim, Seok Jin
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Complementary Roles of Next-Generation Flow and Next-Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma

下一代流式细胞术和下一代测序在多发性骨髓瘤可测量残留病灶评估中的互补作用

期刊:Journal of Korean Medical Science
影响因子:2.3
doi:10.3346/jkms.2026.41.e5
Park, Min-Seung; Lim, Dae Jin; Kim, Hee-Jin; Cho, Duck; Yoon, Sang Eun; Kim, Seok Jin; Kim, Kihyun; Kim, Hyun-Young
多发性骨髓瘤
细胞生物学
FCM
骨髓瘤
发表日期：2026
文献求助 收藏

Comparison of SHAP and clinician friendly explanations reveals effects on clinical decision behaviour

SHAP解释与临床友好型解释的比较揭示了其对临床决策行为的影响

期刊:npj Digital Medicine
影响因子:15.1
doi:10.1038/s41746-025-01958-8
Hur, Sujeong; Lee, Yura; Park, Joongheum; Jeon, Yeong Jeong; Cho, Jong Ho; Cho, Duck; Lim, Dobin; Hwang, Wonil; Cha, Won Chul; Yoo, Junsang
发表日期：2025
文献求助 收藏

Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery

利用微流控基因递送推进同种异体NK细胞免疫疗法

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202412544
Kim, Hyelee; Lee, Mujin; Han, Bohwa; Kim, Jinho; Cho, Duck; Doh, Junsang; Chung, Aram J
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Tumor-priming CD8(+) natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma

肿瘤启动型CD8(+)自然杀伤T样细胞作为一种治疗复发/难治性多发性骨髓瘤的有效新型细胞疗法

期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00707-7
Lee, Juheon; Choi, Eunjeong; Han, Bohwa; Kim, Jeong-A; Jung, Dana; Kim, Kyeong-Hee; Oh, Sung Yong; Kim, Sung-Hyun; Ha, Kyung-Soo; Kim, Ji-Hoon; Lee, Ji Hyun; Cho, Duck; Doh, Junsang; Kim, Seok-Ho
CD8
细胞生物学
多发性骨髓瘤
骨髓瘤
肿瘤
肿瘤免疫
T细胞
发表日期：2025
文献求助 收藏

A Case of Bidirectional ABO- and RhD-Incompatible Liver Transplantation in a Mongolian Patient With Asian-Type DEL

一例蒙古族亚洲型DEL患者接受双向ABO和RhD血型不相容肝移植的病例报告

期刊:Annals of Laboratory Medicine
影响因子:3.9
doi:10.3343/alm.2024.0399
Kang, Takho; Choi, Ryoojung; Kim, Dong-Sik; Cho, Duck; Kim, Dae Won
发表日期：2025
文献求助 收藏

Evaluation of Six Large Language Models for Clinical Decision Support: Application in Transfusion Decision-making for RhD Blood-type Patients

六种大型语言模型在临床决策支持中的应用评估：以RhD血型患者的输血决策为例

期刊:Annals of Laboratory Medicine
影响因子:3.9
doi:10.3343/alm.2024.0588
Lee, Jong Kwon; Choi, Sooin; Park, Sholhui; Hwang, Sang-Hyun; Cho, Duck
发表日期：2025
文献求助 收藏